Grunenthal Logo

External Link

You are now leaving the Grünenthal website. You will be re-directed to an external website. Grünenthal accepts no responsibility for the content of other websites.

Title
Description
Trial IDHP7030-03
CompoundGRT7030
Trials sponsorGrünenthal GmbH
Trial phase1
Brief titleA comparison of how likely it is that different tablets of oxycodone will be broken up and snorted by adults who sometimes take drugs for pleasure
IndicationHealthy
UTNU1111-1203-4920
CTG IDNCT03765346
CTIS ID (former EudraCT)
Trial statusCompleted
FPIJuly 24, 2018
LPONovember 20, 2018
CountriesNetherlands
GenderAll
Age> 18 years
ResultsNo
Pubmed
Documentshp7030-03-lay-summary-en
hp7030-03-lay-summary-fr
hp7030-03-synopsis-red-final